Aerie pharmaceuticals announces presentation at the ophthalmology innovation summit glaucoma innovation showcase

Durham, n.c.--(business wire)--aerie pharmaceuticals, inc. (nasdaq: aeri), an ophthalmic pharmaceutical company, today announced that tom mitro, president and chief operating officer presented an overview on aerie's glaucoma franchise at the ophthalmology innovation summit glaucoma innovation showcase. the slide presentation provides an update on aerie's franchise growth in the united states, as well as progress toward market entry in europe and japan. the slide presentation from today's event
AERI Ratings Summary
AERI Quant Ranking